Mariella M Self1, Danita I Czyzewski2, Bruno P Chumpitazi3, Erica M Weidler4, Robert J Shulman4. 1. Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas; Department of Pediatrics, Baylor College of Medicine, Houston, Texas; Texas Children's Hospital, Houston, Texas. Electronic address: mmself@texaschildrens.org. 2. Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas; Department of Pediatrics, Baylor College of Medicine, Houston, Texas; Texas Children's Hospital, Houston, Texas. 3. Department of Pediatrics, Baylor College of Medicine, Houston, Texas; Texas Children's Hospital, Houston, Texas. 4. Department of Pediatrics, Baylor College of Medicine, Houston, Texas; Texas Children's Hospital, Houston, Texas; U.S. Department of Agriculture/Agricultural Research Service Children's Nutrition Research Center, Houston, Texas.
Abstract
BACKGROUND & AIMS: Pharmacologic treatments for irritable bowel syndrome (IBS) and medical management of symptoms are increasingly based on IBS subtype, so it is important to accurately differentiate patients. Few studies have classified subtypes of pediatric IBS, and conclusions have been challenged by methodologic limitations. We performed a prospective study to investigate the distribution of IBS subtypes among children and adolescents based on stool diary information, and compared subtypes according to demographic and pain characteristics. METHODS: We studied 129 subjects, ages 7 to 18 years (mean age, 11.4 ± 2.8 y; 60.5% female; 69.0% white) who met Pediatric Rome III IBS criteria and were part of larger studies of children with functional gastrointestinal disorders, recruited from primary and tertiary care centers. Children completed daily pain and stool diaries for 2 weeks. Participants were assigned IBS subtypes based on their reported stool information per adult Rome III criteria. IBS subtypes were compared for demographic variables and pain characteristics. RESULTS: IBS with constipation was the most common subtype of the disorder (58.1% of subjects), whereas mixed IBS was the least common (2.3% of subjects); 34.1% of subjects were unsubtyped IBS and 5.4% had IBS with diarrhea. The groups of different IBS subtypes did not differ significantly by sex, age, ethnicity, or pain characteristics. CONCLUSIONS: In contrast to adults, in children, IBS with constipation and unsubtyped IBS are the most common subtypes, whereas IBS with diarrhea and mixed IBS are less common. Demographic and pain characteristics cannot distinguish subtypes.
BACKGROUND & AIMS: Pharmacologic treatments for irritable bowel syndrome (IBS) and medical management of symptoms are increasingly based on IBS subtype, so it is important to accurately differentiate patients. Few studies have classified subtypes of pediatric IBS, and conclusions have been challenged by methodologic limitations. We performed a prospective study to investigate the distribution of IBS subtypes among children and adolescents based on stool diary information, and compared subtypes according to demographic and pain characteristics. METHODS: We studied 129 subjects, ages 7 to 18 years (mean age, 11.4 ± 2.8 y; 60.5% female; 69.0% white) who met Pediatric Rome III IBS criteria and were part of larger studies of children with functional gastrointestinal disorders, recruited from primary and tertiary care centers. Children completed daily pain and stool diaries for 2 weeks. Participants were assigned IBS subtypes based on their reported stool information per adult Rome III criteria. IBS subtypes were compared for demographic variables and pain characteristics. RESULTS:IBS with constipation was the most common subtype of the disorder (58.1% of subjects), whereas mixed IBS was the least common (2.3% of subjects); 34.1% of subjects were unsubtyped IBS and 5.4% had IBS with diarrhea. The groups of different IBS subtypes did not differ significantly by sex, age, ethnicity, or pain characteristics. CONCLUSIONS: In contrast to adults, in children, IBS with constipation and unsubtyped IBS are the most common subtypes, whereas IBS with diarrhea and mixed IBS are less common. Demographic and pain characteristics cannot distinguish subtypes.
Authors: S A Müller-Lissner; I Fumagalli; K D Bardhan; F Pace; E Pecher; B Nault; P Rüegg Journal: Aliment Pharmacol Ther Date: 2001-10 Impact factor: 8.171
Authors: Per M Hellström; Yuri A Saito; Peter Bytzer; Jan Tack; Stefan Mueller-Lissner; Lin Chang Journal: Am J Gastroenterol Date: 2011-03-29 Impact factor: 10.864
Authors: Douglas A Drossman; Carolyn B Morris; Yuming Hu; Brenda B Toner; Nicholas Diamant; Jane Leserman; Michael Shetzline; Christine Dalton; Shrikant I Bangdiwala Journal: Gastroenterology Date: 2005-03 Impact factor: 22.682
Authors: D I Czyzewski; M M Lane; E M Weidler; A E Williams; P R Swank; R J Shulman Journal: Aliment Pharmacol Ther Date: 2010-12-08 Impact factor: 8.171
Authors: Spencer D Dorn; Carolyn B Morris; Yuming Hu; Brenda B Toner; Nicholas Diamant; William E Whitehead; Shrikant I Bangdiwala; Douglas A Drossman Journal: J Clin Gastroenterol Date: 2009-03 Impact factor: 3.062
Authors: B P Chumpitazi; M M Self; D I Czyzewski; S Cejka; P R Swank; R J Shulman Journal: Neurogastroenterol Motil Date: 2015-12-21 Impact factor: 3.598
Authors: Bruno P Chumpitazi; Erica M Weidler; Danita I Czyzewski; Mariella M Self; Margaret Heitkemper; Robert J Shulman Journal: J Pediatr Date: 2016-09-14 Impact factor: 4.406
Authors: James W Varni; Robert J Shulman; Mariella M Self; Samuel Nurko; Miguel Saps; Shehzad A Saeed; Ashish S Patel; Chelsea Vaughan Dark; Cristiane B Bendo; John F Pohl Journal: Qual Life Res Date: 2016-10-14 Impact factor: 4.147
Authors: Robert J Shulman; Mariella M Self; Danita I Czyzewski; Jerry Goldberg; Margaret Heitkemper Journal: J Pediatr Date: 2020-05-04 Impact factor: 4.406
Authors: B P Chumpitazi; J L Cope; E B Hollister; C M Tsai; A R McMeans; R A Luna; J Versalovic; R J Shulman Journal: Aliment Pharmacol Ther Date: 2015-06-24 Impact factor: 8.171
Authors: Erica M Weidler; Mariella M Self; Danita I Czyzewski; Robert J Shulman; Bruno P Chumpitazi Journal: Clin Gastroenterol Hepatol Date: 2016-08-25 Impact factor: 11.382
Authors: Robert J Shulman; Lena Öhman; Mats Stridsberg; Kevin Cain; Magnus Simrén; Margaret Heitkemper Journal: Neurogastroenterol Motil Date: 2018-10-09 Impact factor: 3.598